Application of long-distance polymerase chain reaction to detection of junctional sequences created by chromosomal translocation in mature B-cell neoplasms

Blood

Volumn 88, Issue 3, 1996, Pages 985-994

  Akasaka, Takashi ^b   Muramatsu, Mikiko ^b   Ohno, Hitoshi ^a   Miura, Ikuo ^b   Tatsumi, Eiji ^b   Fukuhara, Shirou ^b   Mori, Toru ^b   Okuma, Minoru ^b  

^a KYOTO UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ANTIGEN DETECTION; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CHROMOSOME TRANSLOCATION; DNA PROBE; EPSTEIN BARR VIRUS; GENE REARRANGEMENT; GENOME; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR CLONING; ONCOGENE C MYC; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TUMOR CELL LINE;

EID: 0029785234     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.3.985.985     Document Type: Article

References (50)

1. Rowley JD: Biological implications of consistent chromosome rearrangements in leukemia and lymphoma. Cancer Res 44:3159, 1984
2. Rabbitts TH: Chromosomal translocations in human cancer. Nature 372:143, 1994
3. Cleary ML: Oncogenic conversion of transcription factors by chromosomal translocations. Cell 66:619, 1991
4. Morgan GJ, Shiach C, Potter M: The clinical value of detecting gene rearrangements in acute leukaemias. Br J Haematol 88:459, 1994
5. Cotter FE: The role of the bcl-2 gene in lymphoma. Br J Haematol 75:449, 1990
6. Haluska FG, Tsujimoto Y, Croce CM: The molecular genetics of non-Hodgkin's lymphomas, in Magrath IT (ed): The Non-Hodgkin's Lymphomas. London, UK, Edward Arnold, 1990, p 96
7. Ohno H, Doi S, Yabumoto K, Fukuhara S, McKeithan TW: Molecular characterization of the t(14;19)(q32;q13) translocation in chronic lymphocytic leukemia. Leukemia 7:2057, 1993
8. Cheng S, Fockler C, Barnes WM, Higuchi R: Effective amplification of long targets from cloned inserts and human genomic DNA. Proc Natl Acad Sci USA 91:5695, 1994
9. Robertson M: Paradox and paradigm: the message and meaning of myc. Nature 306:733, 1983
10. Dalla-Favera R, Martinotti S, Gallo RC, Erikson J, Croce CM: Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas. Science 219:963, 1983
11. Wiman KG, Clarkson B, Hayday AC, Saito H, Tonegawa S, Hayward WS: Activation of a translocated c-myc gene: Role of structural alterations in the upstream region. Proc Natl Acad Sci USA 81:6798, 1984
12. Ohno H, Amakawa R, Fukuhara S: Gene involvement in Japanese 14q+ marker-positive cancer. Acta Haematol Jpn 51:202, 1988
13. Kamamoto T, Sakoda H, Taniguchi Y, Kamesaki H, Kita K, Ohno H, Fukuhara S, Umadome Y, Ohkubo T, Yoshida Y, Uchino H: Establishment and characterization of an Epstein-Barr virus-negative B cell lymphoma cell line with a 14q+ chromosome abnormality. Jpn Arch Int Med 32:241, 1985
14. Abe M, Tasaki K, Tominaga K, Fukuhara S, Imai S, Osato T, Wakasa H: Characterization and comparison of two newly established Epstein-Barr virus (EBV)-negative and EBV-positive Burkitt's lymphoma cell lines. Cancer 69:763, 1992
15. Miki T, Kawamata N, Hirosawa S, Aoki N: Gene involved in the 3q27 translocation associated with B-cell lymphoma, BCL5, encodes a Krüppel-like zinc-finger protein. Blood 83:26, 1994
16. McKeithan TW, Ohno H, Diaz MO: Identification of a transcriptional unit adjacent to the breakpoint in the 14;19 translocation of chronic lymphocytic leukemia. Genes Chrom Cancer 1:247, 1990
17. Deweindt C, Kerckaert J-P, Tilly H, Quief S, Nguyen VC, Bastard C: Cloning of a breakpoint cluster region at band 3q27 involved in human non-Hodgkin's lymphoma. Genes Chrom Cancer 8:149, 1993
18. Reedman BM, Klein G: Cellular localization of an Epstein-Barr virus (EBV)-associated complement fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer 11:499, 1973
19. Shimakage M, Chatani M, Ikegami N, Hirai K: Rearranged Epstein-Barr virus genomes and clonal origin in nasopharyngeal carcinoma. Jpn J Cancer Res 80:612, 1989
20. Yabumoto K, Ohno H, Doi S, Edamura S, Arita Y, Akasaka T, Matsumoto J, Kadowaki N, Fukuhara S, Okuma M: Involvement of the BCL3 gene in two patients with chronic lymphocytic leukemia. Int J Hematol 59:211, 1994
21. Lefranc M-P, Rabbitts TH: Human immunoglobulin heavy chain A2 gene allotype determination by restriction fragment length polymorphism. Nucleic Acids Res 12:1303, 1984
22. Ohno H, Akasaka T, Ohmura K, Nakamura T, Gohma I, Masuya M, Amano H, Imanaka T, Ohno Y: Non-Hodgkin's lymphomas with chromosomal translocations involving 3q27 band and immunoglobulin gene loci: Report of two cases. Cancer Genet Cyto-genet 72:33, 1994
23. Ohno H, Kerckaert J-P, Bastard C, Fukuhara S: Heterogeneity in B-cell neoplasms associated with rearrangement of the LAZ3 gene on chromosome band 3q27. Jpn J Cancer Res 85:592, 1994
24. Hieter PA, Hollis GF, Korsmeyer SJ, Waldmann TA, Leder P: Clustered arrangement of immunoglobulin X constant region genes in man. Nature 294:536, 1981
25. Flanagan JG, Lefranc M-P, Rabbitts TH: Mechanisms of divergence and convergence of the human immunoglobulin α1 and α2 constant region gene sequences. Cell 36:681, 1984
26. Ohno H, Takimoto G, McKeithan TW: The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 60:991, 1990
27. Kawamata N, Miki T, Fukuda T, Hirosawa S, Aoki N: The organization of the BCL6 gene. Leukemia 8:1327, 1994
28. Battey J, Moulding C, Taub R, Murphy W, Stewart T, Potter H, Lenoir G, Leder P: The human c-myc oncogene: structural consequences of translocation into the IgH locus in Burkitt lymphoma. Cell 34:779, 1983
29. Word CJ, White MB, Kuziel WA, Shen AL, Blattner FR, Tucker PW: The human immunoglobulin Cμ-Cδ locus: Complete nucleotide sequence and structural analysis. Int Immunol 1:296, 1990
30. Ellison J, Hood L: Linkage and sequence homology of two human immunoglobulin y heavy chain constant region genes. Proc Natl Acad Sci USA 79:1984, 1982
31. Bensmana M, Lefranc M-P: Gene segments encoding membrane domains of the human immunoglobulin gamma 3 and alpha chains. Immunogenetics 32:321, 1990
32. Hisajima H, Nishida Y, Nakai S, Takahashi N, Ueda S, Honjo T: Structure of the human immunoglobulin C∈2 gene, a truncated pseudogene: Implications for its evolutionary origin. Proc Natl Acad Sci USA 80:2995, 1983
33. Suzuki K, Miki T, Kawamata N, Hirosawa S, Yoshizawa K, Kiyosawa K, Aoki N: Variant translocation of the BCL6 gene to immunoglobulin K light chain gene in B-cell lymphoma. Jpn J Cancer Res 85:911, 1994
34. Stavnezer-Nordgren J, Kekish O, Zegers BJM: Molecular defects in a human immunoglobulin K chain deficiency. Science 230:458, 1985
35. Ye BH, Rao PH, Chaganti RSK, Dalla-Favera R: Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma. Cancer Res 53:2732, 1993
36. Baron BW, Nucifora G, McCabe N, Espinosa III R, Le Beau MM, McKeithan TW: Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22) (q27;q11) in B-cell lymphomas. Proc Natl Acad Sci USA 90:5262, 1993
37. Potter MN, Cross NCP, van Dongen JJM, Saglio G, Oakhill A, Bartram CR, Goldman JM: Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma: An updated meeting report and review. Leukemia 7:1302, 1993
38. Yamada M, Wasserman R, Lange B, Reichard BA, Womer RB, Rovera G: Minimal residual disease in childhood B-lineage lymphoblastic leukemia: Persistence of leukemic cells during the first 18 months of treatment. N Engl J Med 323:448, 1990
39. Trainor KJ, Brisco MJ, Wan JH, Neoh S, Grist S, Morley AA: Gene rearrangement in B- and T-lymphoproliferative disease detected by the polymerase chain reaction. Blood 78:192, 1991
40. H gene rearrangement events can modify the immunoglobulin heavy chain during progression of B-lineage acute lymphoblastic leukemia. Blood 79:223, 1992
41. Vose JM, Anderson JR, Kessinger A, Bierman PJ, Coccia P, Reed EC, Gordon B, Armitage LO: High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. J Clin Oncol 11:1846, 1993
42. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink H-K, Pileri SA, Pins MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group. Blood 84:1361, 1994
43. Ye BH, Lista F, Lo Coco F, Knowles DM, Offit K, Chaganti RSK, Dalla-Favera R: Alterations of a zinc finger-encoding gene, BCLS, in diffuse large-cell lymphoma. Science 262:747, 1993
44. Offit K, Jhanwar S, Ebrahim SAD, Filippa D, Clarkson BD, Chaganti RSK: t(3;22)(q27;q11): A novel translocation associated with diffuse non-Hodgkin's lymphoma. Blood 74:1876, 1989
45. Gribben JG, Freedman AS, Neuberg D, Roy DC, Blake KW, Woo SD, Grossbard ML, Rabinowe SN, Coral F, Freeman GJ, Ritz J, Nadler LM: Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 325:1525, 1991
46. Cory S: Activation of cellular oncogenes in hemopoietic cells by chromosome translocation. Adv Cancer Res 47:189, 1986
47. Kobayashi H, Miki T, Nakamura Y, Kaneko Y: BCL6 gene stays on the der(3) chromosome in a t(3;22)(q27;q11) or t(3;14)(q27;q32) associated with non-Hodgkin's lymphoma. Genes Chrom Cancer 13:225, 1995
48. Pettersson S, Cook GP, Bruggemann M, Williams GT, Neuberger MS: A second B cell-specific enhancer 3′ of the immunoglobulin heavy-chain locus. Nature 344:165, 1990
49. Bastard C, Deweindt C, Kerckaert JP, Lenormand B, Rossi A, Pezzella F, Fruchart C, Duval C, Monconduit M, Tilly H: LAZ3 rearrangements in non-Hodgkin's lymphoma: Correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients. Blood 83:2423, 1994
50. The Non-Hodgkin's Lymphoma Pathologic Classification Project: National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. Cancer 49:2112, 1982